Seungho Lee, Ph.D.

Seungho Lee, PhD, is a co-founder and Chief Executive Officer of SUTOL Bio. He leads the company's corporate strategy, fundraising, and the translation of its technology from academic research into clinically and commercially viable products. Trained in biomedical engineering, his work focuses on materials-driven drug delivery systems and translational technologies, with an emphasis on bridging engineering innovation with regulatory and clinical realities.

He played a central role in the invention of SUTOL's gram-scale, monthly oral capsule within the Langer and Traverso laboratories, guiding its progression from early prototypes to a scalable system designed to improve patient adherence and reduce disease burden.